One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1016/j.jval.2023.03.2241
Copy DOI
Export
Save
Share
Cite Journal: Value in Health |  Publication Date: Jun 1, 2023 |
Affiliation: AbbVie (United States)
A prospective, exploratory, non-treatment study was conducted to characterize the severity of signs and symptoms of Meibomian Gland Dysfunction (MGD). We report the results of the MGD Impact Questionnaire (MGD IQ), developed using FDA guidance and utilized to characterize the severity of disease impact on vision related activities.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
